title: Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.
abstract: The risk of intrauterine transmission of cytomegalovirus (CMV) during pregnancy is much greater for women who contract primary CMV infection after conception than for women with evidence of infection (circulating CMV antibodies) before conception. Thus, laboratory tests that aid in the identification of recent primary CMV infection are important tools for managing the care of pregnant women suspected of having been exposed to CMV. CMV IgM detection is a sensitive marker of primary CMV infection, but its specificity is poor because CMV IgM is also produced during viral reactivation and persists following primary infection in some individuals. Studies conducted over the last 20 years convincingly demonstrate that measurement of CMV IgG avidity is both a sensitive and a specific method for identifying pregnant women with recent primary CMV infection and thus at increased risk for vertical CMV transmission. IgG avidity is defined as the strength with which IgG binds to antigenic epitopes expressed by a given protein; it matures gradually during the 6 months following primary infection. Low CMV IgG avidity is an accurate indicator of primary infection within the preceding 3 to 4 months, whereas high avidity excludes primary infection within the preceding 3 months. In this minireview, we summarize published data demonstrating the clinical utility of CMV IgG avidity results for estimating time since primary infection in pregnant women, describe commercially available CMV IgG avidity assays, and discuss some of the issues and controversies surrounding CMV IgG avidity testing during pregnancy.
authors.affiliation: Focus Diagnostics Reference Laboratory, Cypress, California, USA hprince@focusdx.com.
authors.forename: Harry E
authors.initials: HE
authors.lastname: Prince
authors.affiliation: Focus Diagnostics Reference Laboratory, Cypress, California, USA.
authors.forename: Mary
authors.initials: M
authors.lastname: Lapé-Nixon
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D000915:Antibody Affinity; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D013997:Time Factors
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G